Andrew Raubitschek
Overview
Explore the profile of Andrew Raubitschek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
2214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cahan B, Leong L, Wagman L, Yamauchi D, Shibata S, Wilzcynski S, et al.
Cancer Biother Radiopharm
. 2017 Sep;
32(7):258-265.
PMID: 28910150
Objectives: Report the feasibility, toxicities, and long-term results of a Phase I/II trial of Y-labeled anticarcinoembryonic antigen (anti-CEA) (cT84.66) radioimmunotherapy (RIT), gemcitabine, and hepatic arterial infusion (HAI) of fluorodeoxyuridine (FUdR)...
2.
Mei M, Wondergem M, Palmer J, Shimoni A, Hasenkamp J, Tsai N, et al.
Biol Blood Marrow Transplant
. 2014 Aug;
20(12):2072-5.
PMID: 25079874
Transformation from indolent non-Hodgkin lymphoma (NHL) to diffuse large B cell lymphoma (DLBCL) has historically been associated with a poor prognosis. A small series of autologous stem cell transplantation (ASCT)...
3.
Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain D, et al.
Cancer Res
. 2013 Oct;
73(24):7211-21.
PMID: 24154870
Cancer radiotherapy may be immunogenic, but it is unclear why its immunogenic effects are rarely sufficient to prevent tumor recurrence. Here, we report a novel Toll-like receptor 9 (TLR9)-dependent mechanism...
4.
Nechaev S, Gao C, Moreira D, Swiderski P, Jozwiak A, Kowolik C, et al.
J Control Release
. 2013 Jun;
170(3):307-15.
PMID: 23777886
Dicer-substrate siRNAs equipped with CpG oligodeoxyribonucleotides overcome the major hurdle in cell-specific siRNA delivery. The CpG-siRNA molecules are actively internalized by TLR9+ cells, without the need for transfection reagents, leading...
5.
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
Zhang Q, Sakib Hossain D, Nechaev S, Kozlowska A, Zhang W, Liu Y, et al.
Blood
. 2013 Jan;
121(8):1304-15.
PMID: 23287859
STAT3 operates in both cancer cells and tumor-associated immune cells to promote cancer progression. As a transcription factor, it is a highly desirable but difficult target for pharmacologic inhibition. We...
6.
Yazaki P, Lee B, Channappa D, Cheung C, Crow D, Chea J, et al.
Protein Eng Des Sel
. 2012 Nov;
26(3):187-93.
PMID: 23175797
A series of anti-tumor/anti-chelate bispecific antibody formats were developed for pre-targeted radioimmunotherapy. Based on the anti-carcinoembryonic antigen humanized hT84.66-M5A monoclonal antibody and the anti-DOTA C8.2.5 scFv antibody fragment, this cognate...
7.
Fan H, Zhang I, Chen X, Zhang L, Wang H, Da Fonseca A, et al.
Clin Cancer Res
. 2012 Aug;
18(20):5628-38.
PMID: 22904105
Purpose: Recently, we showed that intratumoral delivery of low-dose, immunostimulatory CpG oligodeoxynucleotides conjugated with carbon nanotubes (CNT-CpG) was more effective than free CpG and not only eradicated intracranial (i.c.) gliomas...
8.
Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, et al.
Cancer Cell
. 2012 May;
21(5):642-654.
PMID: 22624714
Recent studies underscore the importance of myeloid cells in rendering distant organs hospitable for disseminating tumor cells to colonize. However, what enables myeloid cells to have an apparently superior capacity...
9.
Till B, Jensen M, Wang J, Qian X, Gopal A, Maloney D, et al.
Blood
. 2012 Feb;
119(17):3940-50.
PMID: 22308288
Cellular immune responses have the potential to elicit dramatic and sustained clinical remissions in lymphoma patients. Recent clinical trial data demonstrate that modification of T cells with chimeric antigen receptors...
10.
Krishnan A, Palmer J, Tsai N, Simpson J, Nademanee A, Raubitschek A, et al.
Biol Blood Marrow Transplant
. 2011 Aug;
18(3):441-50.
PMID: 21801706
We conducted a matched-cohort analysis of autologous transplant conditioning regimens for diffuse large cell lymphoma in 92 patients treated with either radioimmunotherapy (RIT) or total body irradiation (TBI)-based conditioning regimens....